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Abstract. 
 
The human cytomegalovirus protein, US11, 
initiates the destruction of MHC class I heavy chains by 
targeting them for dislocation from the ER to the cyto-
sol and subsequent degradation by the proteasome. We 
report the development of a permeabilized cell system 
that recapitulates US11-dependent degradation of class 
I heavy chains. We have used this system, in combina-
tion with experiments in intact cells, to identify and or-
der intermediates in the US11-dependent degradation 
pathway. We ﬁnd that heavy chains are ubiquitinated 
before they are degraded. Ubiquitination of the cytoso-
lic tail of heavy chain is not required for its dislocation 
and degradation, suggesting that ubiquitination occurs 
after at least part of the heavy chain has been dislo-
cated from the ER. Thus, ubiquitination of the heavy 
chain does not appear to be the signal to start disloca-
tion. Ubiquitinated heavy chains are associated with 
membrane fractions, suggesting that ubiquitination oc-
curs while the heavy chain is still bound to the ER 
membrane. Our results support a model in which US11 
co-opts the quality control process by which the cell de-
stroys misfolded ER proteins in order to speciﬁcally de-
grade MHC class I heavy chains.
Key words: ubiquitin • US11 • dislocation • endoplas-
mic reticulum • quality control
 
M
 
HC
 
 class I molecules display intracellularly de-
rived peptides on the surface of almost all nucle-
ated mammalian cells for recognition by the im-
mune system. MHC class I heavy chain, which contains the
peptide binding site, is a classical type I transmembrane
protein with a large luminal/extracellular domain and a
short cytosolic tail. The heavy chain enters the secretory
pathway via the ER translocon, a channel whose major
component is Sec61. The light chain 
 
b
 
2
 
 microglobulin
(
 
b
 
2
 
m)
 
1
 
 and the peptide associate with the heavy chain af-
ter it has been inserted into the ER membrane, and the
complex is then transported, via the Golgi, to the plasma
membrane. In humans, the MHC class I heavy chain is a
43-kD protein that contains a single N-linked glycan.
Human cytomegalovirus (HCMV) evades detection by
the immune system by targeting MHC class I heavy chains
for destruction soon after they have been synthesized. The
HCMV proteins responsible for MHC class I heavy chain
destruction are US11 and US2 (Jones et al., 1995). Either
protein, when stably expressed in human tissue culture
cells, causes rapid transport of heavy chains from the ER
to the cytosol, in a process called dislocation. The heavy
chains are subsequently degraded by the proteasome
(Wiertz et al., 1996a,b). US11 and US2 are both small,
transmembrane glycoproteins proteins (
 
,
 
30 kD) that lo-
calize to the ER. They are 21% identical and 45% similar
to each other (Ahn et al., 1996). Whereas US11 seems to
be a typical type I membrane protein, the mode of mem-
brane insertion of US2 remains to be determined. It is
thought that each protein might affect the degradation of
only a subset of the human MHC class I heavy chain al-
leles (Jones et al., 1995).
Specific inhibitors of the proteasome, such as lactacys-
tin and carboxybenzyl-leucyl-leucyl-leucine vinyl sulfone
(ZL
 
3
 
VS) (Bogyo et al., 1997), stabilize MHC class I heavy
chains in cells expressing US11 or US2 (Wiertz et al.,
1996a,b). In the presence of these inhibitors, soluble, degly-
cosylated heavy chains accumulate in the cytosol. Degly-
cosylation is carried out by an 
 
N
 
-glycanase activity (Suzuki
et al., 1994), which, in removing the glycans, converts the
asparagine residue to which they were conjugated to an as-
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Abbreviations used in this paper: 
 
b
 
2
 
m, 
 
b
 
2
 
 microglobulin; Endo H, en-
doglycosidase H; HA, hemagglutinin; HCMV, human cytomegalovirus;
HC, MHC class I heavy chain; IEF, isoelectric focusing; Staph A, fixed
 
Staphylococcus aureus
 
 bacteria; TfR, transferrin receptor; Ub, ubiquitin;
wt, wild-type; ZL
 
3
 
VS, carboxybenzyl-leucyl-leucyl-leucine vinyl sulfone. 
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partic acid. Thus, accumulation of deglycosylated heavy
chains can be monitored both as a shift in molecular mass
(43 kD to 40 kD, by SDS-PAGE) and as a shift in isoelec-
tric point.
Some properties of US11/US2-dependent heavy chain
degradation are also characteristic of ER quality control
(Kopito, 1997; Sommer and Wolf, 1997). This process,
conserved from yeast to human cells, functions to ensure
that only properly folded and assembled proteins exit the
ER for the Golgi on their way through the secretory path-
way. Misfolded proteins or misassembled complexes are
retained in the ER, at least in part because they are bound
by ER-resident chaperones such as BiP and calnexin. Ac-
cumulated proteins that do not fold or assemble properly
are eventually destroyed. Although the proteases respon-
sible were long thought to reside in the ER, the emerging
model is that misfolded proteins are actually dislocated
from the ER and destroyed in the cytosol by the protea-
some. Both US11/US2-dependent degradation of class I
heavy chain and degradation of at least some misfolded
secretory proteins require ATP and the maintenance of a
proper redox potential across the ER membrane (Mc-
Cracken and Brodsky, 1996; Qu et al., 1996; Tortorella et al.,
1998). Furthermore, the membrane channel for disloca-
tion may be the same as for translocation, the Sec61 com-
plex (Wiertz et al., 1996b; Pilon et al., 1997; Plemper et al.,
1997).
A major difference between the destruction of class I
heavy chain via the US11/US2 pathway and the destruc-
tion of other ER proteins is the rate of degradation. The
half-life of MHC class I heavy chain in US11- and US2-
expressing cells is 
 
,
 
3 min (Wiertz et al., 1996a,b), while
the estimated half-lives of misfolded proteins range from
15 min to 
 
.
 
1 h, depending on the protein examined (for
example, see Finger et al., 1993; Yuk and Lodish, 1993;
Ward et al., 1995; Biederer et al., 1996; Yu et al., 1997).
This difference may simply reflect the role played by US11
or US2 in expediting dislocation of heavy chain from the
ER. Once in the cytosol, all dislocated proteins might fol-
low the same path to proteasomal destruction. However,
differences in putative degradation intermediates have also
been noted. In the quality control process, ubiquitinated
degradation intermediates, or requirements for ubiquitin
conjugation machinery, have been demonstrated in many
cases (for example, see Ward et al., 1995; Hiller et al.,
1996; Hampton and Bhakta, 1997; deVirgilio et al., 1998),
while deglycosylated degradation substrates have been re-
ported in the case of only three proteins, MHC class I
heavy chain expressed in the absence of 
 
b
 
2
 
m, CFTR, and
T cell receptor 
 
a
 
 subunit (Hughes et al., 1997; Huppa and
Ploegh, 1997; Yu et al., 1997; Johnston et al., 1998). In con-
trast, deglycosylated class I heavy chain is readily observed
in the US11/US2 pathway, but no ubiquitinated heavy
chain intermediates have been detected (Wiertz et al.,
1996a,b). Thus, experiments to date leave open the possi-
bility that the pathway by which US11 and US2 destroy
class I heavy chain is distinct from the process by which
misfolded secretory proteins are degraded.
To address the mechanisms of the HCMV-induced deg-
radation of MHC class I heavy chains, we have focused on
the US11-dependent dislocation pathway. We have devel-
oped a permeabilized cell system that recapitulates critical
 
aspects of US11-dependent dislocation and degradation of
the class I heavy chain that have been observed in intact
cells. We have used this system, in combination with ex-
periments carried out in intact cells, to demonstrate the
existence of ubiquitinated heavy chain intermediates. We
find that ubiquitination of the heavy chain cytosolic tail is
not required for its US11-dependent dislocation or degra-
dation. Moreover, ubiquitinated heavy chain is associated
with membranes, suggesting that ubiquitination of heavy
chain occurs after it has been dislocated from the ER but
while it is still bound to the ER membrane. These obser-
vations have allowed us to order the basic steps of the
pathway of MHC class I heavy chain destruction. They
demonstrate that the HCMV pathway for heavy chain de-
struction is similar in major respects to ER quality control,
and strongly support the hypothesis that US11 co-opts the
cellular quality control process to destroy MHC class I
heavy chains.
 
Materials and Methods
 
Cells and Cell Culture
 
Control and US11-expressing U373-MG astrocytoma cells (Jones et al.,
1995) were cultured as described previously (Wiertz et al., 1996a).
 
Pulse–Chase Analysis: Intact Cells
 
Cells were detached from tissue culture flasks with trypsin and incubated
in suspension in methionine- and cysteine-free DME for 1 h at 37
 
8
 
C. Cells
at 1
 
 3 
 
10
 
7
 
/ml were pulse-labeled for 10 min at 37
 
8
 
C in 290 
 
m
 
Ci/ml [
 
35
 
S]me-
thionine and cysteine (
 
35
 
S-Protein Express Labeling Mix; New England
Nuclear). At the beginning of the chase period, 5 mM nonradioactive me-
thionine and 1 mM cysteine were added. Samples were taken at various
timepoints and lysates were made as described below. In all pulse–chase
experiments, whether on intact or permeabilized cells (see below), when
present, the proteasome inhibitor ZL
 
3
 
VS (Bogyo et al., 1997) was at 50 
 
m
 
M
throughout.
 
Pulse–Chase Analysis: Permeabilized Cells
 
Cells were labeled as described above, but for only 3 min, placed on
ice, and washed once with PBS. They were then resuspended at 1.6 
 
3
 
 10
 
7
 
cells/ml in PB (25 mM Hepes
 
 
 
7.3, 115 mM potassium acetate, 5 mM so-
dium acetate, 2.5 mM MgCl
 
2
 
, 0.5 mM EGTA) containing 0.025% digito-
nin (Merck, purified as described in Gorlich and Rapoport, 1993), an
ATP-regenerating system (Feldman et al., 1997), and protease inhibitors
(10 
 
m
 
g/ml leupeptin, 5 
 
m
 
g/ml chymostatin, 3 
 
m
 
g/ml elastatinal, and 1 
 
m
 
g/ml
pepstatin). After a chase period at 37
 
8
 
C, lysates were made from samples
taken at various time points and immunoprecipitations were carried out as
described below. 5 min into the chase period, 
 
.
 
95% of cells were perme-
able to Trypan blue and 
 
.
 
90% of their lactate dehydrogenase activity was
released (Tan et al., 1992; data not shown).
 
Mechanical Homogenization and Fractionation
by Centrifugation
 
Permeabilized cells were resuspended at 6
 
 3 
 
10
 
6
 
 cell equivalents/ml in ho-
mogenization buffer (PB with 250 mM sucrose, PMSF, aprotinin, and leu-
peptin). Homogenization was carried out using a ball bearing device
(Balch and Rothman, 1985). The homogenates were fractionated by cen-
trifuging sequentially at 1,000
 
 g
 
 for 10 min, 10,000
 
 g
 
 for 30 min, and
100,000
 
 g
 
 for 1 h, and the resulting pellets were resuspended in homogeni-
zation buffer. The resuspended pellets and the 100,000
 
 g
 
 supernatant were
diluted with NP-40 lysis buffer and immunoprecipitations were carried out
as described below. In the experiments shown in Fig. 12, the intact cells
were resuspended at a concentration of 1.2 
 
3 
 
10
 
7
 
 cells/ml in homogeniza-
tion buffer that contained an ATP regenerating system (Feldman et al.,
1997). 
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Fractionation by Squeeze-Out Centrifugation
 
Soluble, cytosolic proteins were squeezed out of permeabilized cells by
centrifugation. At the indicated chase times, two samples were taken from
each permeabilization reaction. Both were centrifuged in a microfuge at
14,000 rpm at 4
 
8
 
C for 10 min. The supernatant and pellet of one sample
were remixed to represent the total starting material. The supernatant of
the other sample was removed and saved. The pellet fraction was resus-
pended in PB containing digitonin and the ATP regenerating system. Ly-
sates of each fraction (total, supernatant, and pellet) were made and im-
munoprecipitations were carried out, as described below.
 
Proteolysis Protection Experiments
 
Samples from the permeabilization reactions were added to ice-cold
trypsin in PB, such that the final trypsin concentration in each reaction
was as indicated (see Fig. 4). After 30 min on ice, trypsin digestion was
stopped by the addition of the protease inhibitors PMSF and N
 
a
 
-
 
tosyl-lys
chloromethyl ketone, hydrochloride (TLCK; Calbiochem-Novabiochem).
Denaturing SDS lysates were made and heavy chains were immunopre-
cipitated as described below.
 
3
 
H-Mannose Labeling
 
US11 astrocytomas were harvested, washed once in DME containing calf
serum and glucose at 0.45 g/liter, and resuspended at 2 
 
3 
 
10
 
6
 
 cells/ml in
the same media containing 1 mCi/ml 
 
3
 
H-mannose (New England Nuclear)
with or without 50 
 
m
 
M ZL
 
3
 
VS. After labeling at 37
 
8
 
C for 1 h with frequent
agitation, denaturing SDS lysates were made and sequential immunopre-
cipitations with 
 
a
 
HC and 
 
a
 
Ub serum were carried out as described below
and in the legend to Fig. 6 B.
 
Lysate Preparation and Immunoprecipitation
 
As noted in the figure legends, lysates were made in three different ways,
depending on the experiment. In all cases, 1–2
 
 3 
 
10
 
6
 
 cells (or cell equiva-
lents) were used to make 1–1.5 ml of lysate for each immunoprecipitation.
The type of lysate did not affect the overall outcome of any of the immu-
noprecipitation experiments (data not shown), although the yield of im-
munoprecipitated heavy chain was greater when SDS was present. Non-
denaturing NP-40 lysates were made by resuspending cell pellets,
permeabilized cells, or cell fractions so that the final buffer was 0.5% NP-
40 (or Igepal CA-630; Sigma Chemical Co.), 50 mM Tris, pH 8, and 10 mM
MgCl
 
2
 
. Samples were agitated for 20 min at 4
 
8
 
C and then clarified by cen-
trifuging in a microfuge at full speed for 10 min. The resulting supernatant
was used for immunoprecipitation. Denaturing SDS lysates were made by
resuspending cell pellets, permeabilized cells, or cell fractions in 100–150 
 
m
 
l
of 1% SDS and 2 mM DTT. Samples were heated to 95
 
8
 
C for 5 min,
cooled to room temperature, agitated vigorously, and diluted into NP-40
buffer so that the final lysate used for immunoprecipitation was 0.1%
SDS, 0.2 mM DTT, 0.5% Igepal, 50 mM Tris, pH 8, and 10 mM MgCl
 
2
 
. In
some experiments (Figs. 7, 9, C and D, 11, and 12), nondenaturing NP-40
lysates were made and then SDS and DTT were added after the clarifying
spin to final concentrations of 0.1% and 0.2 mM, respectively. All immune
complexes were recovered by precipitation with fixed 
 
Staphylococcus au-
reus
 
 bacteria (Staph A).
 
Antibodies
 
Anti-heavy chain serum (
 
a
 
HC) was made by injecting rabbits with the lu-
minal domains (amino acids 1-275) of both HLA-A2 and HLA-B27 that
had been expressed in bacteria (kindly provided by D. Garboczi, Harvard
University). This serum recognizes free MHC class I heavy chains, as did a
similar antibody which was described previously (Neefjes et al., 1986).
Antibodies were raised against purified bovine ubiquitin (Baboshina and
Haas, 1996) exactly as described (Haas and Bright, 1985). The quality of
the 
 
a
 
Ub serum that was obtained was evaluated in Western blots by its
ability to bind Cdc34p-linked multi-ubiquitin conjugates (Banerjee et al.,
1993; kindly provided by Seth Sadis, Harvard Medical School). US11 anti-
serum was raised in rabbits against a mixture of three US11 peptides
(MPELSLTLFDEPPPLVETE, ESLVAKRYWLRDYRVPQRT, and
FWGLYVKGWLHRHFPWMF) that were coupled to keyhole limpet
hemocyanin. The monoclonal antibody 12CA5, which recognizes the in-
fluenza hemagglutinin (HA) epitope, was purified from tissue culture cell
supernatants by standard methods (Harlow and Lane, 1988). The mono-
 
clonal antibody 66Ig10 was used to immunoprecipitate transferrin recep-
tor (TfR; van de Rijn et al., 1983).
 
Con A Precipitations
 
Immunoprecipitated heavy chains were eluted from Staph A by heating to
95
 
8
 
C in 2% SDS and then diluted into Con A precipitation buffer (final
conditions: 0.5 M NaCl, 50 mM Tris, pH 7.5, 1 mM CaCl
 
2
 
, 1 mM MgCl
 
2
 
,
1 mM MnCl
 
2
 
, 0.5% Igepal, 0.1% SDS, and 0.1% BSA). Con A–Sepharose
(Pharmacia Biotech) was added and samples were mixed gently for 15 h at
4
 
8
 
C. The precipitates were washed four times in Con A precipitation
buffer before being analyzed by SDS PAGE.
 
Gel Electrophoresis
 
One-dimensional isoelectric focusing (IEF), and fluorography were car-
ried out as described previously (Ploegh, 1995). Quantitation of proteins
labeled with 
 
35
 
S and 
 
125
 
I was done with a Fuji PhosphorImager BAS1000.
Densitometry on gels of 
 
3
 
H-mannose–labeled proteins was done with a
BioRad Fluor-S MultiImager.
 
HA/A2 Constructs and Cell Lines
 
HLA-A*0201 heavy chain (HLA-A2), with the mouse H-2 K
 
b
 
 signal se-
quence replacing its own (Story et al., 1999), was cloned into the
pcDNA3.1 expression vector (Invitrogen Corp.). An HA epitope tag
(Surdej and Jacobs-Lorena, 1994) was inserted in the 
 
a
 
2 domain at amino
acid 127, where amino acid 1 is the first amino acid of the protein after the
signal sequence is removed. For the K
 
®
 
R HA/A2 construct, site-directed
mutagenesis and standard cloning techniques were used to change the
three lysine residues in the cytosolic tail (positions 311, 316, and 340) to
arginines. The HA/A2 constructs were transfected into US11 and control
astrocytoma cells using Superfect (Qiagen). Cell lines stably expressing
wild-type (wt) HA/A2 or K
 
®
 
R HA/A2 astrocytomas were selected with
G418-sulfate (GIBCO BRL).
 
125
 
I-Ubiquitin
 
Bovine ubiquitin (Sigma Chemical Co.) was iodinated using chloramine T
(Ciechanover et al., 1980). Each 310-
 
m
 
l iodination reaction contained 2.6
mg/ml ubiquitin, 3.5 mCi/ml Na
 
125
 
I (NEN Life Science Products), and 0.33
mg/ml chloramineT in 0.32 M potassium phosphate, pH 7.6. Iodination
was allowed to proceed for 1 min and was stopped by addition of sodium
metabisulfite and nonradioactive NaI. Iodinated ubiquitin was separated
from unincorporated Na
 
125
 
I by running Sephadex G-25 (Pharmacia Bio-
tech) spin columns that had been equilibrated with PB. The final ubiquitin
concentration was estimated to be 200 
 
m
 
M, labeled to 10,000–15,000 cpm/
pmol. 
 
125
 
I-ubiquitin was added to US11 cells in permeabilization reactions
at a final concentration of 60 
 
m
 
M (see Fig. 6 A) or 15 
 
m
 
M (see Fig. 9 A).
 
Results
 
A Permeabilized Cell System for US11-dependent 
Dislocation and Degradation of MHC Class I
Heavy Chains
 
To begin to dissect the mechanism of US11-dependent dis-
location and degradation of MHC class I heavy chains, a
permeabilized cell system was developed. We devised per-
meabilization conditions, using the mild detergent digito-
nin, such that cells appear microscopically intact, but are
permeable to Trypan blue and ATP as well as to proteins
such as hexokinase, trypsin, and lactate dehydrogenase
(see below and Materials and Methods). In a typical ex-
periment, human astrocytoma cells expressing US11 or
control astrocytoma cells were pulse-labeled briefly at
37
 
8
 
C with [
 
35
 
S]methionine to load the endoplasmic reticu-
lum (ER) with radioactive MHC class I heavy chains. La-
beled cells were permeabilized by incubation in a buffer
containing a low concentration of digitonin and an ATP-
regenerating system, and returned to 37
 
8
 
C for a chase pe- 
The Journal of Cell Biology, Volume 146, 1999 48
 
riod. Lysates were made from samples taken at various
timepoints and class I heavy chains were recovered by im-
munoprecipitation with rabbit anti-heavy chain serum
(
 
a
 
HC).
As in intact cells (Fig. 1 A, lanes 1–3 and 7–9), in the
permeabilized cell system, heavy chains were degraded
only when US11 was present (Fig. 1 B compare lanes 1–6
with lanes 7–12). The half-life of MHC class I heavy chain
in permeabilized US11 cells was 
 
z
 
10 min (Fig. 1 C), some-
what longer than its 2–3-min half-life in intact US11 cells
(Wiertz et al., 1996a). In the presence of the proteasome
inhibitors ZL
 
3
 
VS (Fig. 1 D) or lactacystin (data not
shown), degradation was largely prevented and a lower
molecular mass heavy chain species accumulated in US11
cells. This species is endoglycosidase H (Endo H) resistant
(data not shown) and its molecular mass by SDS-PAGE
corresponds to that of the deglycosylated heavy chain spe-
cies that accumulates in the cytosol of intact US11 cells
treated with proteasome inhibitors (Fig. 1 A lanes 4–6). As
was observed in intact cells, the change in molecular mass
of the heavy chain in the permeabilized cells is accompa-
nied by a change in isoelectric point upon hydrolysis of the
glycoamide bond. This is best seen by comparison with
bacterial 
 
N
 
-glycanase (PNGase F) treated samples (Fig. 2
compare lane 3 with lanes 2 and 6). Thus, deglycosylated
heavy chains also accumulate in permeabilized US11 cells
in the presence of proteasome inhibitor.
As in intact cells, the deglycosylated heavy chains in the
permeabilized cells were soluble and cytosolic (Fig. 3 A).
The glycosylated heavy chains from both permeabilized
US11 and control cells fractionated mostly with the partic-
ulate fractions, as did the control membrane proteins
transferrin receptor (TfR) and US11. The light chain 
 
b
 
2
 
m,
a soluble secretory protein, fractionated with membrane
pellets in permeabilized control cells, as expected from its
tight association with the MHC class I heavy chain. In
US11 cells, because there is little heavy chain, most of the
 
b
 
2
 
m is soluble in the ER lumen (Wiertz et al., 1996a). We
found 
 
b
 
2
 
m in both the 10-K pellet and the 100-K superna-
tant fractions in permeabilized US11 cells (Fig. 3 A), indi-
cating that a portion of the ER content was released dur-
ing homogenization.
Because the mechanical homogenization was a rather
harsh procedure, resulting in some disruption of vesicles,
a squeeze-out fractionation technique was also applied.
At each timepoint after permeabilization, samples were
taken, subjected to centrifugation in a microfuge, and sep-
arated into pellet and supernatant fractions. Under these
conditions, 
 
b
 
2
 
m fractionated identically in US11 and con-
Figure 1. MHC class I heavy chain dislocation and degradation
in intact cells and permeabilized cells. (A) The fate of class I
heavy chain in intact control and US11 cells. Astrocytoma cells
were pulse-labeled for 10 min with [35S]methionine and chased,
intact, at 378C. Samples were taken at the indicated times and
cells were lysed with NP-40 lysis buffer. Immunoprecipitations
were carried out using rabbit anti–heavy chain serum (aHC).
Where indicated, the cells were incubated with the proteasome
inhibitor ZL3VS. The bands corresponding to glycosylated heavy
chain (HC1CHO) and deglycosylated heavy chain (HC-CHO)
are labeled. (B) Heavy chain is degraded in permeabilized US11
cells. US11 cells and control cells were pulse-labeled for 3 min
with [35S]methionine, permeabilized, and chased at 378C for the
indicated times. Samples were lysed with NP-40 lysis buffer and
class I heavy chain was recovered by immunoprecipitation with
aHC serum. (C) The data in B, quantitated on a PhosphorIm-
ager. (D) Deglycosylated heavy chain accumulates in US11 cells
permeabilized in the presence of the proteasome inhibitor
ZL3VS. Cells were labeled, permeabilized, and chased exactly as
in B, but in the presence of ZL3VS. Multiple closely spaced heavy
chain bands that could often be separated by SDS-PAGE are
likely the products of different alleles of MHC class I heavy chain
present in the astrocytoma cells.
Figure 2. IEF demonstrates that deglycosylated heavy chains ac-
cumulate in permeabilized US11 cells. Samples from the experi-
ment shown in Fig. 1 D were treated or mock-treated with
PNGase F as indicated, and analyzed by one-dimensional IEF as
described (Ploegh, 1995). Arrows point to bands corresponding
to deglycosylated MHC class I heavy chains. The different HLA
gene products migrate with disparate, though characteristic, iso-
electric points. 
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trol cells, 
 
.
 
90% of the 
 
b
 
2
 
m was found in the pellet frac-
tions, confirming that little disruption of vesicles occurred.
US11 was found only in pellet fractions (data not shown).
The deglycosylated heavy chain was found mostly in the
squeezed-out, soluble fractions (Fig. 3 B, lanes 6 and 9)
whereas the glycosylated heavy chain was found in the
membrane pellet fractions.
The cytosolic localization of the deglycosylated heavy
chain in permeabilized cells was confirmed by proteolysis
protection experiments. Samples of permeabilized cells
were treated with increasing amounts of trypsin. Trypsin
at 100 
 
m
 
g/ml degraded nearly all of the deglycosylated
heavy chain present, while the glycosylated, membrane-
bound heavy chain was largely protected (Fig. 4 A). Fur-
ther experiments showed that the faster-migrating heavy
chain species, seen at 100 mg/ml and 200 mg/ml trypsin,
corresponds to glycosylated heavy chain lacking the 30–
amino acid cytosolic tail. It was not immunoprecipitable
with antibodies specific for the heavy chain cytosolic tail
(data not shown) and it was sensitive to treatment with
endo H (Fig. 4 B). Thus, deglycosylated heavy chain in
permeabilized US11 cells accumulates in the cytosol and
not in a membrane-bound compartment.
In intact astrocytomas expressing US11 or US2, accu-
mulation of deglycosylated heavy chain requires ATP
(Wiertz et al., 1996b; Tortorella, D., unpublished observa-
tion). To test whether this also applies to the permeabi-
lized cell system, we depleted ATP from permeabilization
reactions carried out in the presence of proteasome inhibi-
tor. Simply omitting the ATP-regenerating system from
the permeabilization reactions significantly reduced the
amount of deglycosylated heavy chain that appeared (Fig.
5, lanes 5–8). When remaining ATP was depleted by the
addition of hexokinase and glucose, no deglycosylated
heavy chain was detectable (Fig. 5, lanes 9–12). Moreover,
ATP could not be substituted with the nonhydrolyzable
ATP analogue AMPPNP (Fig. 5, lanes 13–16). Thus, as in
intact cells, the US11-dependent accumulation of deglyco-
sylated heavy chain in permeabilized cells requires ATP.
Taken together, these data demonstrate that the perme-
abilized cell system faithfully reproduces the US11-depen-
dent degradation of MHC class I heavy chain seen in in-
tact cells.
A Ubiquitinated MHC Class I Heavy
Chain Intermediate
Although ubiquitin conjugates of ER proteins degraded in
the course of quality control have been detected in both
mammalian cells and in yeast (Ward et al., 1995; Hiller et al.,
Figure 3. Deglycosylated heavy chain from permeabilized US11
cells is soluble. US11 and control cells were labeled, permeabi-
lized, and chased in the presence of the proteasome inhibitor
ZL3VS as described for Fig. 1 D. (A) Fractionation after homog-
enization. After 30 min of chase at 378C, the cells were homoge-
nized mechanically and the homogenates were fractionated by
centrifugation. Fractions were diluted into NP-40 lysis buffer and
immunoprecipitation was carried out with antibodies to HC,
transferrin receptor (TfR), b2m, or US11. (B) Fractionation by
squeeze-out centrifugation (see Materials and Methods). Total
starting material (T), pellet (P), and supernatant (S) fractions are
labeled. Denaturing SDS lysates were made and immunoprecipi-
tations were carried out with aHC serum.
Figure 4. Deglycosylated heavy chain is preferentially accessible
to protease in permeabilized cells. US11 and control cells were
labeled, permeabilized, and chased in the presence of the protea-
some inhibitor ZL3VS as described for Fig. 1 D. After 30 min of
chase at 378C, samples from the permeabilization reactions were
treated on ice with trypsin, at the final concentrations indicated.
Denaturing SDS lysates were made and MHC class I heavy
chains were immunoprecipitated with aHC serum. (A) Immuno-
precipitation products were analyzed directly by SDS PAGE.
Proteolysis produced a glycosylated heavy chain species that
lacks its cytoplasmic tail (HCDtail1CHO). (B) The indicated im-
munoprecipitation products from (A) were treated (1) or mock-
treated (2) with Endo H (New England Biolabs) before SDS
PAGE.The Journal of Cell Biology, Volume 146, 1999 50
1996; Hampton and Bhakta, 1997; Mayer et al., 1998),
ubiquitinated MHC class I heavy chains in cells infected
with HCMV or in cells expressing US11 or US2 have not
been reported. We used a direct and sensitive method to
test for the presence of ubiquitinated heavy chain interme-
diates in permeabilized US11 cells. Instead of metaboli-
cally labeling cells before permeabilization, we perme-
abilized the cells in the presence of 125I-ubiquitin. After a
10-min incubation at 378C, lysates were made and heavy
chains were isolated by immunoprecipitation. Iodinated,
high molecular mass heavy chain species accumulated in
permeabilized US11 cells, but only when proteasome in-
hibitor was present (Fig. 6 A, lanes 2 and 3). Much less of
this material was seen in control cells, despite the presence
of proteasome inhibitors (lane 5). The high molecular
mass of the iodinated products is consistent with their be-
ing polyubiquitin-conjugated MHC class I heavy chains.
They are not coimmunoprecipitating ubiquitinated pro-
teins, because they are also immunoprecipitable with aHC
antibody from permeabilized cells lysed under denaturing
conditions (data not shown). Nor are they conjugates
formed after lysis, because the appearance of 125I-ubiquitin
heavy chains requires incubation with permeabilized cells
(lane 4).
To establish in intact cells that similar ubiquitin conju-
gates occur, anti-ubiquitin antibodies were raised and used
in immunoprecipitation experiments. US11 and control
cells were pulse-labeled with [35S]methionine for 10 min
and chased at 378C in the absence or presence of protea-
Figure 5. Appearance of deglycosylated heavy chain in perme-
abilized US11 cells requires ATP. (Lanes 1–4) US11 cells were
labeled, permeabilized, and chased in the presence of the protea-
some inhibitor ZL3VS as described for Fig. 1 D. (Lanes 5–16)
Prepared as in lanes 1–4, except that the ATP regenerating sys-
tem was omitted from the permeabilization buffers and with the
additions as indicated. Glucose was at 10 mM, hexokinase was at
0.1 unit/ml, and AMPPNP and magnesium acetate were each at
3 mM. Note that some degradation of heavy chain occurs in the
absence of ATP. This degradation is not inhibitable by the addi-
tion of proteasome inhibitor (ZL3VS) or standard protease inhib-
itors (aprotinin, leupeptin, pepstatin, chymostatin, or elastatinal)
and has not been characterized further.
Figure 6. Identification of a ubiquitinated heavy chain intermediate. (A) 125I-ubiquitin labels heavy chains in permeabilized US11 cells
(lanes 2–5). US11 and control cells were incubated in solution in the presence or absence of ZL3VS for 1 h. Cells were then incubated
with permeabilization buffer containing 125I-labeled ubiquitin. After incubation at 378C for 10 min, NP-40 lysates were made and sub-
jected to immunoprecipitation with aHC serum followed by SDS PAGE analysis. The mock permeabilization reaction (lane 4) con-
tained no digitonin. [35S]methionine-labeled heavy chain immunoprecipitates from another experiment were run alongside the 125I-
labeled samples (lane 1). The migration of molecular mass markers is indicated at the left of the gel. This figure is a composite of
nonconsecutive lanes from a single exposure of one gel. (B) Ubiquitinated heavy chain intermediates in 35S-labeled US11 cells in vivo.
US11 and control cells were pulse-labeled with [35S]methionine and chased intact at 378C in the absence or presence of ZL3VS as de-
scribed for Fig. 1 A. Denaturing SDS lysates were made from samples taken at each timepoint and these were diluted with NP-40
buffer. A first immunoprecipitation was carried out with aHC serum, followed by incubation with Staph A. Bound material was eluted
with SDS and one-third of each sample was analyzed directly by SDS PAGE and autoradiography (lanes 1–16). The remaining two
thirds of each sample was diluted into NP-40 buffer and reimmunoprecipitated with anti-ubiquitin serum (aUb) or mock-immunopre-
cipitated (no serum added, M) before SDS PAGE (lanes 17–32). Background bands that precipitate with Staph A alone are identified
by the mock immunoprecipitations (*). The migration of molecular mass markers is indicated at the right of the lower gel. Exposure time
of the gel for lanes 1–16 is 20 h, and for lanes 17–32 is 30 d.Shamu et al. A Ub-HC Intermediate in US11-dependent Dislocation 51
some inhibitor. MHC class I heavy chains were immuno-
precipitated and the material bound to the aHC antibod-
ies was dissociated and denatured with SDS. One aliquot
was analyzed directly (Fig. 6 B, lanes 1–16), and the rest
was diluted into immunoprecipitation buffer and sub-
jected to a second round of immunoprecipitation with
anti-ubiquitin serum (aUb). High molecular mass, ubiq-
uitin-conjugated heavy chains were detected in US11 cells
but not in control cells (Fig. 6 B, lanes 17–24 vs. lanes 25–
32). Some nonubiquitinated heavy chains were also recov-
ered, probably due to nonspecific interactions (lanes 17,
21, 25, and 29). Thus, MHC class I heavy chain is ubiquiti-
nated in intact US11 cells just as it is in permeabilized
cells.
In the absence of proteasome inhibitor, a small amount
of heavy chain was found ubiquitinated immediately after
labeling (Fig. 6 B, lane 18), but subsequently disappeared
during the chase period, presumably because it was de-
graded. In the presence of proteasome inhibitor, the
amount of ubiquitinated heavy chain observed remained
essentially constant throughout the chase period (lanes
22–24). This probably reflects a balance in the action of
ubiquitinating and deubiquitinating enzymes in the ab-
sence of appreciable degradation of the heavy chain.
The majority of heavy chain in US11 cells is not ubiqui-
tinated. Given the short labeling time in these experiments
and the stability of ubiquitin in cells, we believe that most
of the radioactivity in the ubiquitinated heavy chains is in-
corporated into the heavy chains themselves and not the
ubiquitin molecules. With this assumption, we estimate
that, at most, 10–20% of the MHC class I heavy chains are
ubiquitinated in intact US11 cells treated with proteasome
inhibitor. In the absence of proteasome inhibitor, at most
5% of the heavy chains were ubiquitinated.
Consistent with the observation that dislocation is
slower in permeabilized cells than in intact cells, we found
that accumulation of ubiquitinated heavy chain is also
slower under those conditions (Fig. 7 A). Interest-
ingly,  both deglycosylated heavy chains and ubiquitinated
heavy chains accumulate at approximately the same rate
(Fig. 7 B), suggesting that a common, preceding step is
rate-limiting.
Ubiquitinated Heavy Chains Are Largely
Not Glycosylated
Having demonstrated the occurrence of ubiquitinated
heavy chains, we wished to know whether ubiquitination
precedes deglycosylation or vice versa. Two independent
approaches were taken to determine the fraction of ubiq-
uitinated heavy chains that are glycosylated. First, intact
US11 cells were treated with proteasome inhibitors and la-
beled with 3H-mannose. Very little 3H-mannose-labeled,
ubiquitinated heavy chain was detected. On very long (2 mo)
exposures of gels from three independent experiments, the
amount of 3H-mannose–labeled heavy chain precipitated
with aUb serum was barely above background levels (data
not shown). Furthermore, in aHC immunoprecipitations,
3H-mannose–labeled, nonubiquitinated heavy chains were
efficiently recovered, but very little mannose label was de-
tectable in the area of the high molecular mass, ubiquiti-
nated HC species (Fig. 8 A, lanes 3 and 4). In contrast,
such species were readily detectable in 35S-labeled cells
(Fig. 8 A, lanes 1 and 2). Ubiquitinated glycosylated heavy
chains account, at most, for only 1–2% of all glycosylated
heavy chains in these experiments. Thus, it appears that
the majority of the ubiquitinated heavy chains in US11
cells are deglycosylated.
This finding is supported by a second set of experiments,
in which glycosylated heavy chains were isolated by their
ability to bind the lectin Con A. 35S-labeled ubiquitinated
heavy chains were isolated by immunoprecipitation with
aHC serum, followed by reimmunoprecipitation with aUb
serum. Heavy chains were eluted from the aUb antibodies
with SDS and each sample was divided in two. Half was
analyzed directly by SDS-PAGE and the other half was
precipitated with Con A–Sepharose. Only a very small
amount of ubiquitinated HC precipitated with con A (Fig.
8 B, compare lanes 1 and 2 with lanes 3 and 4). The precip-
itation was specific for glycosylated material because, in
control experiments carried out in parallel, very little de-
glycosylated, nonubiquitinated HC was precipitated with
Con A (Fig. 8 C, lanes 1 and 2). No heavy chain was recov-
Figure 7. Ubiquitin-conjugated and deglycosylated heavy chains
accumulate at the same rate. (A) US11 cells were labeled, perme-
abilized, and chased in the presence of the proteasome inhibitor
ZL3VS as described for Fig. 1 D. aHC immunoprecipitates of
each lysate were split and part was reimmunoprecipitated with
aUb antibodies, as described for the experiments shown in Fig. 6
B. Nonspecific bands that precipitate with Staph A alone are
identified by the asterisk. Note that the exposure of the aHC gel
is 12 h whereas the exposure of the aUb gel is 3 wk. (B) The data
in A were quantitated on a PhosphorImager and graphed. Note
the different scales on the two y axes.The Journal of Cell Biology, Volume 146, 1999 52
ered in samples incubated with Con A in the presence of
the competitor methyl a-D-mannopyranoside (Fig. 8 B,
lanes 5 and 6, Fig. 8 C, lane 3) or in samples incubated only
with Sepharose beads (data not shown). We calculated
that only z10% of the ubiquitinated heavy chains bound
to Con A. Taken together, these data suggest that either
deglycosylation precedes ubiquitination or that ubiquiti-
nated heavy chains are rapidly deglycosylated.
Membrane Association of Ubiquitinated Heavy
Chain Intermediates
Does ubiquitination occur while heavy chains are still as-
sociated with membranes? We first examined permeabi-
lized US11 cells that had been treated with proteasome
inhibitors because ubiquitinated heavy chains are most
abundant under those conditions. In fractionation experi-
ments, after mechanical homogenization of permeabilized
cells that had been incubated in the presence of 125I-ubiq-
uitin, 50% of the ubiquitinated heavy chain was found in
the 100-K supernatant and 30% in the 100-K pellet (Fig. 9
A). In squeeze-out fractionation experiments on perme-
abilized US11 cells labeled with 125I-ubiquitin in the same
way, z75% of 125I-ubiquitinated heavy chains fractionated
with the cytosol (data not shown). A similar result was ob-
tained in 35S-labeled permeabilized US11 cells, where
z80% of ubiquitinated heavy chains fractionated with the
cytosol after 20 min of chase (Fig. 9 B, lanes 10–12). Thus,
most of the ubiquitinated heavy chains in US11 cells
treated with proteasome inhibitors are released from the
ER, although a small percentage seems to be membrane-
associated.
We next examined the localization of ubiquitinated
heavy chain in cells not treated with proteasome inhibi-
tors. To follow the small amount of ubiquitinated heavy
chain that accumulates in intact cells under these condi-
tions, we permeabilized the cells after the chase period
and fractionated their contents using the squeeze-out tech-
nique (see Materials and Methods). We found that almost
all of the ubiquitinated heavy chain fractionated with the
membrane pellets in US11 cells not treated with protea-
some inhibitor (Fig. 9 C, lanes 5–7). This result was not
simply due to the failure to achieve permeabilization be-
cause, under the same conditions, proteasomes and other
cytosolic proteins can be squeezed out of these cells (data
not shown). Moreover, in an experiment carried out in
parallel using cells treated with proteasome inhibitor, de-
glycosylated heavy chain (Fig. 9 D, lanes 2 and 5) and ubiq-
uitinated heavy chains (lanes 8 and 11) were squeezed into
the cytosolic supernatant. Note that in the presence of pro-
teasome inhibitor, the amount of soluble, ubiquitinated
heavy chain increases with time (Fig. 9 D, compare lanes 8
and 9 with lanes 11 and 12). Thus, these results are consis-
tent with those shown in Figs. 9, A and B. They suggest
that, both in the presence and absence of proteasome in-
hibitor, heavy chain is ubiquitinated while it is still associ-
ated with the ER membrane. Over time, in the absence of
proteasome inhibitor, the ubiquitinated heavy chain is de-
graded, while, in the presence of proteasome inhibitor, it is
released into the cytosol.
Figure 8. The majority of ubiq-
uitinated heavy chain is not gly-
cosylated. (A) US11 cells were
labeled with 3H-mannose in the
presence (lane 4) or absence
(lane 3) of ZL3VS, denaturing
SDS lysates were made, and
heavy chains were immunopre-
cipitated with aHC serum.
[35S]methionine-labeled heavy
chain immunoprecipitates from
another experiment (US11 cells
treated with ZL3VS) were run
alongside the 3H-mannose–
labeled samples (lanes 1 and 2).
The asterisk indicates high mo-
lecular mass species, most likely
ubiquitinated heavy chains, that
are immunoprecipitated with
aHC serum. The exposure time
of this gel is 24 d. (B) US11 cells
treated with ZL3VS were la-
beled with [35S]methionine and
chased intact for 0 or 15 min. Denaturing SDS lysates were made and subjected to sequential immunoprecipitation with aHC and aUb
serum, as described for Fig. 6 B. One-half of each aUb precipitate was analyzed directly by SDS PAGE (lanes 1 and 2) and the other
half was precipitated with Con A–Sepharose, either in the presence (1) or absence (2) of 0.5 M methyl a-D-mannopyranoside. Note
that the two panels are from a single exposure (4 wk) of the same gel; the lanes were separated to help clarify the experimental proce-
dure. Nonspecific bands that precipitate with Staph A alone are identified by the asterisk. (C) US11 cells from the experiment shown in
B but chased intact for 7 min. Con A precipitations were done as in B after immunoprecipitation with aHC serum. The two panels are
from a single exposure (3 d) of the same gel.Shamu et al. A Ub-HC Intermediate in US11-dependent Dislocation 53
Ubiquitination of the MHC Class I Heavy Chain Tail Is 
Not Required for US11-dependent Dislocation
and Degradation
With heavy chain ubiquitination occurring at the ER
membrane, it seemed possible that ubiquitination might
be the initiating signal for heavy chain dislocation. To de-
termine whether ubiquitination of the heavy chain is re-
quired for its dislocation, we prevented ubiquitination of
the heavy chain cytosolic tail by removing all lysines from
the tail domain. Two different HA epitope-tagged heavy
chain constructs, based on the HLA allele A2, were made,
one with a wild-type (wt) cytosolic tail and one with the
three cytosolic tail lysines mutated to arginine (K®R).
Cell lines stably expressing the HA-tagged heavy chains
(HA/A2) were selected. We found that K®R HA/A2 is
degraded at approximately the same rate as wt HA/A2 in
US11 cell lines, while both HA/A2 proteins are stable in
control cells (Figs. 10, A and B, and data not shown).
When pulse–chase experiments were conducted in the
presence of proteasome inhibitor, deglycosylated HA-
Figure 9. Fractionation of ubiq-
uitinated heavy chains. (A)
US11 cells treated with ZL3VS
were permeabilized and chased
in the presence of 125I-ubiquitin
as in Fig. 6 A. The cells were
then homogenized and fraction-
ated by centrifugation as in Fig.
3 A. aHC immunoprecipitates
are shown. US11 cells labeled
with [35S]methionine but perme-
abilized without 125I-ubiquitin
were fractionated in a parallel
experiment;  35S-labeled HC,
US11, TfR, and b2m fraction-
ated exactly as in Fig. 3 A (data
not shown). The ubiquitinated
heavy chain in each fraction was
quantitated by PhosphorImager
and the results, expressed as a
percent of the total amount of
ubiquitinated heavy chain, are
shown at the bottom of each
lane. (B) Squeeze-out fraction-
ation was carried out on 35S-
labeled, permeabilized US11
cells treated with ZL3VS as de-
scribed for Fig. 3 B. MHC class I
heavy chains were immunopre-
cipitated with aHC serum fol-
lowed by aUb serum, as in Fig 6
B. The ubiquitinated heavy
chain in the pellet and superna-
tant fractions from the 20-min
time point was quantitated by
PhosphorImager and the results
are shown at the bottom of each
lane. Nonspecific bands that pre-
cipitate with Staph A alone are
identified by the asterisk. Note
that the exposure of the aHC
immunoprecipitate gel is 56 h,
while that of the aUb immuno-
precipitate gel is 3 wk. (C and D)
Squeeze-out fractionation was
carried out on US11 cells in the
absence (C) or presence (D) of
ZL3VS. In this case, cells were
labeled with [35S]methionine and
chased intact, and then permeabilized for 10 min on ice in the presence of 0.025% digitonin and the ATP regenerating system before
squeeze-out centrifugation. Proteins in each fraction were solubilized with buffer containing 0.5% NP-40 and lysates were prepared for
immunoprecipitation as described in Materials and Methods. Sequential immunoprecipitations with aHC serum followed by aUb se-
rum were as in Fig 6 B. Nonspecific bands that precipitate with Staph A alone are identified by the asterisk. Note that the exposure of
the aHC gels in C and D is 16.5 h, while the exposures of the aUb gels are 6 wk (C) and 3 wk (D).The Journal of Cell Biology, Volume 146, 1999 54
tagged wt and K®R heavy chain intermediates accumu-
lated at roughly the same rate (Fig. 10 C). In all cases, the
HA/A2 heavy chains were dislocated and degraded more
slowly than endogenous heavy chain in cells not express-
ing HA/A2 constructs. We attribute this to the overexpres-
sion of the HA/A2 degradation substrates, which may sat-
urate the degradation machinery (Story et al., 1999).
These results were reproducible in multiple, indepen-
dently derived cell lines. Ubiquitination of the heavy chain
cytosolic tail, therefore, is not required to initiate US11-
dependent destruction of the protein.
Next, we asked whether the K®R heavy chain is ubiq-
uitinated. We isolated ubiquitinated HA/A2 from [35S]me-
thionine-labeled cell lines by sequential immunoprecipita-
tion with aHA and aUb antibodies. Ubiquitin-conjugated
K®R HA/A2 was detected in US11 cells both in the ab-
sence (Fig. 11 A, lane 13) or presence (Fig. 11 B, lanes 13
and 16) of proteasome inhibitor. In fact, K®R HA/A2 was
ubiquitinated to approximately the same extent as wt HA/
A2. The finding that dislocated heavy chains are not ubiq-
uitinated exclusively on residues in the cytosolic tail im-
plies that dislocation must start before ubiquitination of
the heavy chain.
In squeeze-out fractionation experiments, the majority
of ubiquitinated K®R HA/A2 and wt HA/A2 fractionated
with membrane pellets in the absence of proteasome in-
hibitors (Fig. 11 A, lanes 13–21). In the presence of protea-
some inhibitors, slightly more than half of the ubiquiti-
nated HA/A2 in each cell line fractionated with the
cytosol (Fig. 11 B, lanes 13–24). These results were con-
firmed in experiments in which the cell lines expressing
the two different HA/A2 alleles were homogenized me-
Figure 10. Ubiquitination of the heavy chain cytoplasmic tail is
not required for its dislocation from the ER. The stability of HA-
tagged MHC class I allele A2 (HA/A2), with either a wt cyto-
plasmic tail (wt) or with a mutant cytoplasmic tail (K®R), was
analyzed in US11 and control cells. Astrocytoma cells stably
expressing the HA/A2 constructs were pulse-labeled and chased
in the absence (A) or in the presence (C) of ZL3VS, and NP-40
lysates were made as described for Fig. 1 A. HA-tagged heavy
chains were immunoprecipitated specifically using monoclonal
antibody 12CA5. (B) The data in A were quantitated by Phos-
phorImager.
Figure 11. HA-tagged heavy chains with either wt or K®R mu-
tant cytoplasmic tails are ubiquitinated. Squeeze-out fraction-
ation, as described for Fig. 9, C and D, was carried out on US11
cells expressing K®R HA/A2 or wt HA/A2. Sequential immuno-
precipitation was done on the fractions as in Fig. 6 B, except that
the monoclonal antibody 12CA5 was used in the first immuno-
precipitation to isolate HA-tagged heavy chains. Experiments
were carried out in the absence (A) or presence (B) of ZL3VS.
Note that the exposure time of the aHA gels in these panels is
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chanically and fractionated by differential centrifugation.
Both ubiquitinated HA/A2 species showed identical frac-
tionation behavior. In the absence of proteasome inhibi-
tors, they were clearly membrane-associated, with most
found in the 1-K pellet (Fig. 12 A). In the presence of pro-
teasome inhibitors, the majority of the ubiquitinated HA/
A2 was in the 100-K pellet and supernatant (Fig. 12 B).
Although we have not characterized the heavy chain in the
100-K pellet fraction further, we have found proteasome
subunits in this fraction as well (data not shown), raising
the possibility that some ubiquitinated heavy chain is
tightly associated with proteasomes in the presence of pro-
teasome inhibitor. Taken together, these data support the
idea that the ER luminal domain of heavy chain is ubiqui-
tinated while the protein is still associated with the mem-
brane.
Discussion
We have developed a permeabilized cell system that reca-
pitulates many of the important aspects of US11-depen-
dent dislocation and degradation of MHC class I heavy
chains that have been observed in intact cells. In the pres-
ence of proteasome inhibitors, deglycosylated heavy chain
accumulates in the cytosolic fraction of permeabilized
cells. As in intact cells, appearance of this deglycosylated
species is ATP-dependent.
We have used this permeabilized cell system, in combi-
nation with experiments carried out in intact cells, to iden-
tify and order intermediates in US11-dependent disloca-
tion. In so doing, we have provided strong evidence that
US11-dependent degradation of class I heavy chain fol-
lows a sequence of events similar to that described for
other proteins that exit the ER for degradation in the cyto-
sol. First, using two independent methods, we have shown
that ubiquitinated MHC class I heavy chains accumulate
in US11 cells. Experiments involving the addition of 125I-
ubiquitin to permeabilized cells followed by immunopre-
cipitation with aHC serum provide direct evidence that
heavy chain is ubiquitinated. Double immunoprecipitation
experiments on lysates of 35S-labeled cells, using antibod-
ies against MHC class I heavy chain and against ubiquitin,
confirmed the identity of the ubiquitinated heavy chain.
Importantly, ubiquitinated heavy chains were detected in
US11 cells regardless of whether they had been treated
with proteasome inhibitors, indicating that they are not an
artifact of proteasome inhibitor addition.
The majority of the ubiquitinated heavy chain that accu-
mulates in US11 cells treated with proteasome inhibitor is
not glycosylated, suggesting that deglycosylation may pre-
cede ubiquitin conjugation. However, the presence of a
small population of glycosylated, ubiquitinated heavy chains
and the observation that, at least in permeabilized US11
cells, ubiquitinated heavy chains seem to accumulate si-
multaneously with deglycosylated heavy chains (Fig. 7),
suggest that there might be no obligatory order to the de-
glycosylation and ubiquitination steps.
We addressed the role of heavy chain ubiquitination in
US11-dependent export from the ER by mutating all of
the lysine residues in the heavy chain cytosolic tail to argi-
nine, creating a K®R heavy chain mutant that lacks poten-
tial ubiquitination sites in its cytosolic domain. This mu-
tant is still dislocated and degraded at approximately the
same rate as wt heavy chain. It is also ubiquitinated. Thus,
ubiquitination of the cytosolic tail of MHC class I heavy
Figure 12. Membrane association of ubiquitinated K®R HA/
A2. US11 cells expressing wt or K®R HA/A2 were labeled for
10 min and then homogenized mechanically, without an interven-
ing chase period. Homogenates were fractionated by centrifuga-
tion as in Fig. 3 A. Proteins in each fraction were solubilized with
buffer containing 0.5% NP-40 and lysates were prepared for im-
munoprecipitation as described in Materials and Methods. Ubiq-
uitinated, HA-tagged heavy chains were isolated by immunopre-
cipitating first with the 12CA5 monoclonal antibody, followed by
reimmunoprecipitation with aUb serum. Different fractions
were also immunoprecipitated for US11 and b2m. Experiments
were carried out in the absence (A) or presence (B) of ZL3VS.
Nonspecific bands that precipitate with Staph A alone are identi-
fied by the asterisk. Note that the exposure of the aHA gel in
each panel is 27 h whereas the exposure of the aUb gels is 3 wk
(A) or 10 d (B).The Journal of Cell Biology, Volume 146, 1999 56
chain is not required to initiate heavy chain dislocation
and degradation.
Our data lead to the following model for US11-depen-
dent degradation of MHC class I heavy chain (Fig. 13).
The first step is dislocation, in which all or part of the lumi-
nal domain of heavy chain enters the cytosol. We do not
know the source of the force that pulls or pushes the heavy
chain from the ER, nor do we know which segment of the
protein exits the ER first. However, once the luminal do-
main of the heavy chain has been dislocated, the protein
seems to undergo ubiquitination while still associated with
the ER membrane. We find ubiquitinated heavy chains,
including the K®R heavy chain mutants, in cell membrane
fractions. Thus, at this stage, the ubiquitinated heavy
chains are either completely dislocated from the ER but
still tightly associated with the membrane on the cytosolic
side (Fig. 13, arrow I), or they are partially dislocated from
the ER, with part of the protein integrated in the ER
membrane or held in the dislocation channel. Partially dis-
located heavy chain could be in two different orientations:
with a portion of the luminal domain situated in the ER
membrane (Fig. 13, arrow II), or, more likely for energetic
reasons, with the transmembrane domain in the ER mem-
brane and with both NH2 and COOH termini in the cyto-
sol (Fig. 13, arrow III). ER membrane-associated ubiq-
uitin-conjugating enzymes have been identified in yeast
and they are required for ER-associated degradation
(Sommer and Jentsch, 1993; Biederer, 1996; Hiller et al.,
1996; Biederer et al., 1997). Our results suggest that simi-
lar enzymes may play a role in US11-dependent heavy
chain degradation.
Ultimately, the heavy chain is degraded. It is not clear
how the heavy chain is brought into contact with the pro-
teasome, nor where degradation takes place. If we assume
that the proteasome inhibitor simply causes a backup of
intermediates of the normal degradation pathway, then
both soluble deglycosylated and soluble ubiquitinated
heavy chains must also be present in the absence of inhibi-
tor, but as very short-lived species. Thus, degradation
would occur on cytosolic proteasomes. Alternatively, it is
possible that the proteasome inhibitor actually alters the
degradation pathway and that the soluble heavy chain spe-
cies are an artifactual consequence of proteasome inhibi-
tion. If this is the case, then heavy chain degradation
would occur at the ER membrane, carried out by a popu-
lation of proteasomes that localizes there (Rivett, 1998).
The work presented here suggests that US11 accelerates
a process that normally occurs with misfolded proteins in
uninfected cells. By inference, US2 probably operates sim-
ilarly. In fact, MHC class I heavy chains are also ubiquiti-
nated in cells expressing US2 (Shamu, C.E., unpublished
observation). Thus, understanding the exact mechanism
by which US11 and US2 induce rapid MHC class I heavy
chain degradation will be important not only for under-
standing viral immune evasion, but also for understanding
ER quality control. The speed and specificity with which
heavy chain is degraded in the presence of US11 will be
particularly useful for further characterization of the dislo-
cation pathway using our permeabilized system. It should
be possible to dissect the cytosolic requirements of the
pathway and to carry out more detailed mechanistic
studies.
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